Zobrazeno 1 - 10
of 292
pro vyhledávání: ''
Autor:
Marisel R. Tuttobene, Tomas Subils, Krisztina M. Papp-Wallace, Marcelo E. Tolmasky, Federico Perez, Maria Soledad Ramirez, Brent Nishimura, Robert A. Bonomo, German Matias Traglia, Casin Le, Camila Pimentel
Publikováno v:
Antimicrob Agents Chemother
Acinetobacter baumannii A118, a mostly susceptible strain, and AB5075, carbapenem-resistant, were cultured in L broth or L broth with different supplements: 3.5% human serum albumin (HSA), human serum (HS), meropenem, or meropenem plus 3.5% HSA. Natu
Autor:
Alan R. Hauser, Fiorella Krapp, Nathan B. Pincus, Chao Qi, Egon A. Ozer, Katherine R. Murphy, Zackery P. Bulman, Eric Wenzler
Publikováno v:
mSystems
mSystems, Vol 6, Iss 5 (2021)
mSystems, Vol 6, Iss 5 (2021)
Carbapenem-resistant Klebsiella pneumoniae strains cause severe infections that are difficult to treat. The production of carbapenemases such as the K. pneumoniae carbapenemase (KPC) is a common mechanism by which these strains resist killing by the
Autor:
Stanley Pang, Terence Lee, Shafi Sahibzada, David Jordan, Sam Abraham, Geoffrey W. Coombs, Rebecca Abraham, Mark O’Dea
Publikováno v:
Appl Environ Microbiol
Enterococci are ubiquitous opportunistic pathogens that have become a major public health issue globally. The increasing prevalence of antimicrobial resistance in hospital-adapted enterococci had been thought to originate from livestock. However, thi
Autor:
Jessie Ausman, Jacob Biboy, Hannah Bovermann, Katie N. Kang, Cara C. Boutte, Joseph M. Boll, Misha I. Kazi, Joe W. Gray, Waldemar Vollmer
Publikováno v:
mBio, Vol 12, Iss 1 (2021)
mBio
mBio
Despite dogma suggesting that lipopolysaccharide/lipooligosaccharide (LOS) was essential for viability of Gram-negative bacteria, several Acinetobacter baumannii clinical isolates produced LOS− colonies after colistin selection. Inactivation of the
Autor:
Malcolm G. P. Page, Jürgen Brem, Christopher J. Schofield, Thomas M. Leissing, Pauline A. Lang
Publikováno v:
Antimicrobial Agents and Chemotherapy
β-Lactam antibiotics are presently the most important treatments for infections by pathogenic Escherichia coli, but their use is increasingly compromised by β-lactamases, including the chromosomally encoded class C AmpC serine-β-lactamases (SBLs).
Autor:
Xun Tao, Alaa R. M. Sayed, Jieqiang Zhou, Arnold Louie, Eunjeong Shin, Weiguo Liu, Yinzhi Lang, Carolin Werkman, Dhruvitkumar S. Sutaria, Nirav Shah, George L. Drusano, Bartolomé Moyá, Yuanyuan Jiao, Manasi Kamat, Kari B. Basso, Jürgen B. Bulitta
Publikováno v:
Antimicrob Agents Chemother
Mycobacterium abscessus causes serious infections that often require over 18 months of antibiotic combination therapy. There is no standard regimen for the treatment of M. abscessus infections, and the multitude of combinations that have been used cl
Autor:
M Jurkovic, Kevin A. Meyer, Eric Wenzler, Zackery P Bulman, A Vialichka, D Lamm, R E Mendes, Mark Biagi, Shree Patel
Publikováno v:
Antimicrob Agents Chemother
The intrinsic L1 metallo- and L2 serine-β-lactamases in Stenotrophomonas maltophilia make it naturally multidrug resistant and difficult to treat. There is a need to identify novel treatment strategies for this pathogen, especially against isolates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226ace1f427ff512c6987331483e057b
https://europepmc.org/articles/PMC7674038/
https://europepmc.org/articles/PMC7674038/
Autor:
Victoire de Lastours, Vincent Cattoir, Bruno Fantin, François Guérin, Françoise Chau, L. Massias, Geoffrey Cheminet, Ariane Roujansky
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2020, 64 (8), pp.e00853-20. ⟨10.1128/AAC.00853-20⟩
Antimicrob Agents Chemother
Antimicrobial Agents and Chemotherapy, 2020, 64 (8), pp.e00853-20. ⟨10.1128/AAC.00853-20⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2020, 64 (8), pp.e00853-20. ⟨10.1128/AAC.00853-20⟩
Antimicrob Agents Chemother
Antimicrobial Agents and Chemotherapy, 2020, 64 (8), pp.e00853-20. ⟨10.1128/AAC.00853-20⟩
The clinical benefit of carbapenems against carbapenemase-producing Enterobacteriaceae (CPE) remains in question. MICs of imipenem (IMP) and ertapenem (ERT) against isogenic derivatives of the wild-type strain Escherichia coli CFT073 producing KPC-3,
Autor:
Saoussen Oueslati, Pascal Retailleau, Rémy A. Bonnin, Bogdan I. Iorga, Thierry Naas, Laurent Dortet, Ludovic Marchini, Camille Berthault
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2020, 64 (5), pp.e02329-19. ⟨10.1128/aac.02329-19⟩
Antimicrob Agents Chemother
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2020, 64 (5), pp.e02329-19. ⟨10.1128/aac.02329-19⟩
Antimicrob Agents Chemother
International audience; Increasing numbers of variants of the carbapenem-hydrolyzing class D β-lactamase OXA-48 are identified in Enterobacterales worldwide. Among them, OXA-181 and OXA-232 are of particular interest, as they differ from each other
Autor:
Hordijk, J., Farmakioti, E., Smit, L.A., Duim, B., Graveland, H., Theelen, M.J.P., Wagenaar, J.A., dI&I I&I-4, One Health Microbieel, dIRAS RA-I&I RA, LS Klinisch Onderzoek Wagenaar, LS Equine Internal Medicine, dES AVR, CS_Welfare & emerging diseases
Publikováno v:
Applied and Environmental Microbiology, 86(8)
Applied and Environmental Microbiology, 86(8), 1. American Society for Microbiology
Applied and Environmental Microbiology 86 (2020) 8
Applied and Environmental Microbiology, 86(8), 1. American Society for Microbiology
Applied and Environmental Microbiology 86 (2020) 8
A nationwide study on the occurrence of extended-spectrum β-lactamase (ESBL)/AmpC in nonhospitalized horses in the Netherlands was performed. Molecular characterization was done, and questionnaires were analyzed to identify factors associated with c